Accéder au contenu
Merck

Dydrogesterone use during pregnancy: overview of birth defects reported since 1977.

Early human development (2009-02-06)
Annette Queisser-Luft
RÉSUMÉ

Between 1977 and 2005, 28 cases of potential links between maternal dydrogesterone use during pregnancy and congenital birth defects were reported. The types of defects were very diverse, with no evidence of a pattern of abnormalities. The data do not provide evidence for congenital malformations associated with dydrogesterone use.

MATÉRIAUX
Référence du produit
Marque
Description du produit

Dydrogesterone, European Pharmacopoeia (EP) Reference Standard